Stieber P - Search Results

1

[Tumor markers--how they should be applied].

Stieber P, Heinemann V, Schalhorn A. Stieber P, et al. MMW Fortschr Med. 2005 May 19;147(20):35, 37-9. MMW Fortschr Med. 2005. PMID: 15957858 German.

2

Prognostic and therapeutic significance of carbohydrate antigen 19-9 as tumor marker in patients with pancreatic cancer.

Boeck S, Stieber P, Holdenrieder S, Wilkowski R, Heinemann V. Boeck S, et al. Among authors: stieber p. Oncology. 2006;70(4):255-64. doi: 10.1159/000094888. Epub 2006 Aug 4. Oncology. 2006. PMID: 16899980 Free article. Review.

3

Assessing prognosis in metastatic pancreatic cancer by the serum tumor marker CA 19-9: pretreatment levels or kinetics during chemotherapy?

Boeck S, Schulz C, Stieber P, Holdenrieder S, Weckbach S, Heinemann V. Boeck S, et al. Among authors: stieber p. Onkologie. 2007 Feb;30(1-2):39-42. doi: 10.1159/000097764. Epub 2007 Jan 26. Onkologie. 2007. PMID: 17264524 Free article.

4

F-18-fluoro-2-deoxyglucose positron emission tomography/computed tomography in the follow-up of breast cancer with elevated levels of tumor markers.

Haug AR, Schmidt GP, Klingenstein A, Heinemann V, Stieber P, Priebe M, la Fougère C, Becker C, Hahn K, Tiling R. Haug AR, et al. Among authors: stieber p. J Comput Assist Tomogr. 2007 Jul-Aug;31(4):629-34. doi: 10.1097/01.rct.0000284394.83696.42. J Comput Assist Tomogr. 2007. PMID: 17882045

5

Clinical relevance of circulating nucleosomes in cancer.

Holdenrieder S, Nagel D, Schalhorn A, Heinemann V, Wilkowski R, von Pawel J, Raith H, Feldmann K, Kremer AE, Müller S, Geiger S, Hamann GF, Seidel D, Stieber P. Holdenrieder S, et al. Among authors: stieber p. Ann N Y Acad Sci. 2008 Aug;1137:180-9. doi: 10.1196/annals.1448.012. Ann N Y Acad Sci. 2008. PMID: 18837945 Review.

6

Preoperative serum markers for individual patient prognosis in stage I-III colon cancer.

Giessen-Jung C, Nagel D, Glas M, Spelsberg F, Lau-Werner U, Modest DP, Schulz C, Heinemann V, Di Gioia D, Stieber P. Giessen-Jung C, et al. Among authors: stieber p. Tumour Biol. 2015 Sep;36(10):7897-906. doi: 10.1007/s13277-015-3522-z. Epub 2015 May 8. Tumour Biol. 2015. PMID: 25953265

7

Tumor markers in the early detection of tumor recurrence in breast cancer patients: CA 125, CYFRA 21-1, HER2 shed antigen, LDH and CRP in combination with CEA and CA 15-3.

Di Gioia D, Blankenburg I, Nagel D, Heinemann V, Stieber P. Di Gioia D, et al. Among authors: stieber p. Clin Chim Acta. 2016 Oct 1;461:1-7. doi: 10.1016/j.cca.2016.07.014. Epub 2016 Jul 22. Clin Chim Acta. 2016. PMID: 27451906

8

Re-evaluation of HER2 status in metastatic breast cancer and tumor-marker guided therapy with vinorelbine and trastuzumab.

Stemmler HJ, Stieber P, Lässig D, Heinemann V. Stemmler HJ, et al. Among authors: stieber p. Onkologie. 2005 Feb;28(2):95-7. doi: 10.1159/000082803. Epub 2005 Feb 3. Onkologie. 2005. PMID: 15692222 Free article.

9

CA19-9: a pedictor of response in pancreatic cancer treated with gemcitabine and cisplatin.

Heinemann V, Schermuly MM, Stieber P, Schulz L, Jüngst D, Wilkowski R, Schalhorn A. Heinemann V, et al. Among authors: stieber p. Anticancer Res. 1999 Jul-Aug;19(4A):2433-5. Anticancer Res. 1999. PMID: 10470171 Clinical Trial.

10

Nucleosomes in serum of patients with benign and malignant diseases.

Holdenrieder S, Stieber P, Bodenmüller H, Busch M, Fertig G, Fürst H, Schalhorn A, Schmeller N, Untch M, Seidel D. Holdenrieder S, et al. Among authors: stieber p. Int J Cancer. 2001 Mar 20;95(2):114-20. doi: 10.1002/1097-0215(20010320)95:2<114::aid-ijc1020>3.0.co;2-q. Int J Cancer. 2001. PMID: 11241322

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

186 results

Search Page

Filters